Caricamento...
Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications: A Prespecified Secondary Analysis of a Randomized Clinical Trial
IMPORTANCE: The Million Hearts Cardiovascular Disease (CVD) Risk Reduction Model pays provider organizations for measuring and reducing Medicare patients’ cardiovascular risk. OBJECTIVE: To assess whether the model increases the initiation or intensification of antihypertensive medications or statin...
Salvato in:
| Pubblicato in: | JAMA Cardiol |
|---|---|
| Autori principali: | , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Medical Association
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8173467/ https://ncbi.nlm.nih.gov/pubmed/34076665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2021.1565 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|